Olfactory neuroblastoma. A clinical analysis of 17 cases
- PMID: 1260676
- DOI: 10.1002/1097-0142(197603)37:3<1571::aid-cncr2820370347>3.0.co;2-l
Olfactory neuroblastoma. A clinical analysis of 17 cases
Abstract
Seventeen patients with olfactory neuroblastoma seen at the Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary from 1941 to 1971 are presented. Data on age, sex, symptoms, physical, and roentgenographic findings, and therapeutic results are evaluated. A system of pretherapy staging is proposed in which for Group A, the tumor is limited to the nasal cavity; in group B, the tumor is localized to the nasal acvity and paranasal sinuses; and in group C, the tumor extends beyond the nasal cavity and paranasal sinuses. Olfactory neuroblastoma is a radioresponsive, and, to a limited extent, radiocurable tumor and varies in aggressiveness. Of 17 patients in this series, 13 or 76% were alive without disease following treatment by surgery, irradiation, and combination of these two methods. Uncontrolled primary lesions with or without metastases accounted for all therapeutic failures. A treatment policy for this disease is presented.
Similar articles
-
[Olfactory neuroblastoma. Apropos of 2 cases].An Otorrinolaringol Ibero Am. 1985;12(4):315-26. An Otorrinolaringol Ibero Am. 1985. PMID: 4025740 Spanish. No abstract available.
-
[Olfactory esthesioneuroma. Apropos of 12 cases].Rev Laryngol Otol Rhinol (Bord). 1992;113(3):185-9. Rev Laryngol Otol Rhinol (Bord). 1992. PMID: 1344533 Review. French.
-
[Esthesioblastoma of the nasal cavity].Vestn Otorinolaringol. 1985 Nov-Dec;(6):40-3. Vestn Otorinolaringol. 1985. PMID: 4090158 Russian. No abstract available.
-
Olfactory neuroblastoma.Cancer. 1989 Jun 15;63(12):2426-8. doi: 10.1002/1097-0142(19890615)63:12<2426::aid-cncr2820631209>3.0.co;2-k. Cancer. 1989. PMID: 2720589
-
Esthesioneuroblastoma: problems with diagnosis and management.Trans Pa Acad Ophthalmol Otolaryngol. 1989;41:897-901. Trans Pa Acad Ophthalmol Otolaryngol. 1989. PMID: 2698527 Review.
Cited by
-
Impact of early radiological response evaluation on radiotherapeutic outcomes in the patients with nasal cavity and paranasal sinus malignancies.J Radiat Res. 2012 Sep;53(5):704-9. doi: 10.1093/jrr/rrs021. Epub 2012 Jul 10. J Radiat Res. 2012. PMID: 22843360 Free PMC article.
-
Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States.J Neurol Surg B Skull Base. 2015 Mar;76(2):94-100. doi: 10.1055/s-0034-1390016. Epub 2014 Sep 29. J Neurol Surg B Skull Base. 2015. PMID: 25844294 Free PMC article.
-
Sinonasal tumors: a clinicopathologic update of selected tumors.Eur Arch Otorhinolaryngol. 2013 Jan;270(1):5-20. doi: 10.1007/s00405-012-2025-4. Epub 2012 May 18. Eur Arch Otorhinolaryngol. 2013. PMID: 22610012 Review.
-
Skull Base Registries: A Roadmap.J Neurol Surg B Skull Base. 2022 Nov 12;83(6):561-578. doi: 10.1055/a-1934-9191. eCollection 2022 Dec. J Neurol Surg B Skull Base. 2022. PMID: 36393883 Free PMC article. Review.
-
Radiation therapy strategies for skull-base malignancies.J Neurooncol. 2020 Dec;150(3):445-462. doi: 10.1007/s11060-020-03569-7. Epub 2020 Aug 12. J Neurooncol. 2020. PMID: 32785868 Review.